Home | Welcome to Contract Pharma   
Last Updated Friday, May 29 2015


Aesica Expands Oral Solids Capabilities

Published July 9, 2014
Aesica Pharmaceuticals has added services to its oral solids capability with a new roller compaction unit for dry granulation production in Zwickau, Germany. The roller compaction unit uses a continuous production step designed to enhance product uniformity for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.
This represents the company’s latest investment in the region, including a new tablet coater capability and pouch packing line.
Ian Muir, managing director, Finished Dose at Aesica, said, “This new investment aligns with our strategy of investing in our German sites to broaden capabilities, which is expanding our domestic market share within Germany, whilst allowing us to offer new services to our global customers. The dry granulation capability will drive business growth as customers with moisture sensitive APIs seek appropriate technologies, and crucially, experienced CDMOs that can deliver their products.”

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On